Twist Bioscience (TWST) Raw Materials (2018 - 2026)

Twist Bioscience has disclosed Raw Materials across 9 years of filings, most recently posting $25.5 million for Q1 2026.

• In Q1 2026, Raw Materials rose 78.74% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $25.5 million (up 78.74% YoY), while the FY2025 annual figure was $20.2 million, up 16.6% from the prior year.
• Raw Materials advanced to $25.5 million in Q1 2026, from $24.7 million in the prior quarter.
• Over the last five years, Raw Materials for TWST reached as high as $33.6 million in Q1 2023 and fell as low as $14.3 million in Q1 2025.
• The 5-year median for Raw Materials is $24.7 million (2025), against an average of $24.7 million.
• Annual changes were most pronounced in 2022 — Raw Materials soared 180.8% — and 2024, when it sank 35.92%.
• A 5-year view of Raw Materials shows it stood at $33.6 million in 2022, then decreased by 29.22% to $23.8 million in 2023, then tumbled by 32.51% to $16.0 million in 2024, then soared by 53.86% to $24.7 million in 2025, then increased by 3.58% to $25.5 million in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $25.5 million, $24.7 million, and $20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.